Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

TSXV:ARCH - Post Discussion

Arch Biopartners Inc > Older article i found interesting
View:
Post by 2019champs on Aug 15, 2021 10:19am

Older article i found interesting

https://www.frontiersin.org/articles/10.3389/fimmu.2020.01446/full "Complete blood picture of COVID-19 patients usually shows lymphopenia with or without total leukopenia. A lymphocyte count <1.0 109/l has been associated with severe disease (18). a recent research has reported that severe cases of covid-19 tend to have higher neutrophil to lymphocyte ratio (nlr). nlr is calculated from a routine blood picture by dividing the absolute neutrophil count by the absolute lymphocyte count and indicates a patient's overall inflammatory status". ="" 109/l="" has="" been="" associated="" with="" severe="" disease="" (18).="" a="" recent="" research="" has="" reported="" that="" severe="" cases="" of="" covid-19="" tend="" to="" have="" higher="" neutrophil="" to="" lymphocyte="" ratio="" (nlr).="" nlr="" is="" calculated="" from="" a="" routine="" blood="" picture="" by="" dividing="" the="" absolute="" neutrophil="" count="" by="" the="" absolute="" lymphocyte="" count="" and="" indicates="" a="" patient's="" overall="" inflammatory="" status".="">
Comment by GoldenArm on Aug 16, 2021 10:23am
Yes interesting read. Thanks. Only correction to be made is that the virus escaped from the Lab in Wuhan. Hence the reason why Chinese goverment is spending millions in advertising with MSM and major news papers to change the narrative. I think this buying media especially news organizations is facinating and I wonder what long term effect of this will be for MSM's  Does China own the US?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities